( May 29, 2025, 2:36 PM EDT) -- FORT WORTH, Texas — Motions for summary judgment in a dispute over the U.S. Food and Drug Administration’s removal of semaglutide, an FDA-approved drug for diabetes and weight loss, from the agency’s drug shortage list were made public on May 28, debating whether the agency’s actions violated federal law....